Vor Biopharma Stock Price Patterns
| VOR Stock | USD 13.62 0.37 2.64% |
Momentum 52
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (2.21) | EPS Estimate Current Year (102.53) | EPS Estimate Next Year (4.61) | Wall Street Target Price 44.6 | EPS Estimate Current Quarter (4.10) |
Using Vor Biopharma hype-based prediction, you can estimate the value of Vor Biopharma from the perspective of Vor Biopharma response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Vor Biopharma using Vor Biopharma's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Vor using crowd psychology based on the activity and movement of Vor Biopharma's stock price.
Vor Biopharma Short Interest
An investor who is long Vor Biopharma may also wish to track short interest. As short interest increases, investors should be becoming more worried about Vor Biopharma and may potentially protect profits, hedge Vor Biopharma with its derivative instruments, or be ready for some potential downside.
200 Day MA 22.3899 | Short Percent 0.0629 | Short Ratio 1.6 | Shares Short Prior Month 2.3 M | 50 Day MA 12.0372 |
Vor Biopharma Hype to Price Pattern
Investor biases related to Vor Biopharma's public news can be used to forecast risks associated with an investment in Vor. The trend in average sentiment can be used to explain how an investor holding Vor can time the market purely based on public headlines and social activities around Vor Biopharma. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Vor Biopharma's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Vor Biopharma.
Vor Biopharma Implied Volatility | 0.0 |
Vor Biopharma's implied volatility exposes the market's sentiment of Vor Biopharma stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Vor Biopharma's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Vor Biopharma stock will not fluctuate a lot when Vor Biopharma's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Vor Biopharma to buy its stock at a price that has no basis in reality. In that case, they are not buying Vor because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Vor Biopharma after-hype prediction price | USD 13.52 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Vor contract
Based on the Rule 16, the options market is currently suggesting that Vor Biopharma will have an average daily up or down price movement of about 0.0% per day over the life of the 2026-04-17 option contract. With Vor Biopharma trading at USD 13.62, that is roughly USD 0.0 . If you think that the market is fully incorporating Vor Biopharma's daily price movement you should consider acquiring Vor Biopharma options at the current volatility level of 0.0%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Vor Biopharma Basic Forecasting Models to cross-verify your projections. Vor Biopharma After-Hype Price Density Analysis
As far as predicting the price of Vor Biopharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Vor Biopharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Vor Biopharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Vor Biopharma Estimiated After-Hype Price Volatility
In the context of predicting Vor Biopharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Vor Biopharma's historical news coverage. Vor Biopharma's after-hype downside and upside margins for the prediction period are 2.98 and 24.06, respectively. We have considered Vor Biopharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Vor Biopharma is slightly risky at this time. Analysis and calculation of next after-hype price of Vor Biopharma is based on 3 months time horizon.
Vor Biopharma Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Vor Biopharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Vor Biopharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Vor Biopharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.19 | 10.54 | 0.10 | 0.01 | 9 Events / Month | 7 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
13.62 | 13.52 | 0.73 |
|
Vor Biopharma Hype Timeline
On the 30th of January Vor Biopharma is traded for 13.62. The entity has historical hype elasticity of -0.1, and average elasticity to hype of competition of 0.01. Vor is estimated to decline in value after the next headline, with the price expected to drop to 13.52. The average volatility of media hype impact on the company price is over 100%. The price depreciation on the next news is expected to be -0.73%, whereas the daily expected return is at this time at -0.19%. The volatility of related hype on Vor Biopharma is about 20386.85%, with the expected price after the next announcement by competition of 13.63. About 44.0% of the company outstanding shares are owned by institutional investors. The company recorded a loss per share of 386.86. Vor Biopharma had not issued any dividends in recent years. The entity had 1:20 split on the 19th of September 2025. Considering the 90-day investment horizon the next estimated press release will be in about 9 days. Check out Vor Biopharma Basic Forecasting Models to cross-verify your projections.Vor Biopharma Related Hype Analysis
Having access to credible news sources related to Vor Biopharma's direct competition is more important than ever and may enhance your ability to predict Vor Biopharma's future price movements. Getting to know how Vor Biopharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Vor Biopharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| FATE | Fate Therapeutics | 0.02 | 8 per month | 0.00 | (0.09) | 7.27 | (7.63) | 20.97 | |
| NKTX | Nkarta Inc | (0.07) | 6 per month | 2.94 | 0.0001 | 4.31 | (4.83) | 12.70 | |
| ACTU | Actuate Therapeutics Common | (0.61) | 5 per month | 0.00 | (0.13) | 5.40 | (7.00) | 20.01 | |
| ALEC | Alector | 0.00 | 7 per month | 3.54 | 0.11 | 5.47 | (7.32) | 17.01 | |
| FBRX | Forte Biosciences | 1.69 | 7 per month | 6.14 | 0.20 | 13.16 | (9.14) | 40.19 | |
| PEPG | PepGen | 0.69 | 7 per month | 6.03 | 0.06 | 10.32 | (9.44) | 31.03 | |
| ANIX | Anixa Biosciences | (0.05) | 11 per month | 0.00 | (0.07) | 8.98 | (6.51) | 40.89 | |
| APLT | Applied Therapeutics | 0.01 | 9 per month | 0.00 | (0.23) | 10.00 | (15.73) | 83.66 | |
| MCRB | Seres Therapeutics | (1.12) | 8 per month | 6.72 | (0.01) | 9.13 | (7.64) | 54.10 | |
| SPRO | Spero Therapeutics | (0.04) | 9 per month | 2.75 | 0.0004 | 3.64 | (5.04) | 13.07 |
Vor Biopharma Additional Predictive Modules
Most predictive techniques to examine Vor price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Vor using various technical indicators. When you analyze Vor charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Vor Biopharma Predictive Indicators
The successful prediction of Vor Biopharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Vor Biopharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Vor Biopharma based on analysis of Vor Biopharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Vor Biopharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Vor Biopharma's related companies.
Pair Trading with Vor Biopharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vor Biopharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vor Biopharma will appreciate offsetting losses from the drop in the long position's value.Moving together with Vor Stock
Moving against Vor Stock
| 0.62 | ZYME | Zymeworks Common Stock | PairCorr |
| 0.33 | ZBIO | Zenas BioPharma Common | PairCorr |
| 0.31 | SUNFF | Sun Life Financial | PairCorr |
The ability to find closely correlated positions to Vor Biopharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vor Biopharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vor Biopharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vor Biopharma to buy it.
The correlation of Vor Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vor Biopharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vor Biopharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vor Biopharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Vor Stock Analysis
When running Vor Biopharma's price analysis, check to measure Vor Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vor Biopharma is operating at the current time. Most of Vor Biopharma's value examination focuses on studying past and present price action to predict the probability of Vor Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vor Biopharma's price. Additionally, you may evaluate how the addition of Vor Biopharma to your portfolios can decrease your overall portfolio volatility.